Vafseo® approved by the U.S. FDA for the treatment of a

/PRNewswire/ -- CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved...

Related Keywords

Melbourne , Victoria , Australia , Japan , Switzerland , United States , Thomas Hutter , Glennm Chertow , Clin Nephrol , Steering Committee , Drug Administration , Fresenius Medical Care , Vifor International , Akebia Therapeutics Inc , National Institute Of Diabetes , Clin Lab Haematol , National Institutes Of Health , Division Of Nephrology At Stanford University , Akebia Therapeutics , General Manager , Stanford University , Executive Steering Committee , New England Journal , Important Safety Information , Fresenius Kidney Care , Vifor Fresenius Medical Care Renal Pharma , Safety Information , Myocardial Infarction , Venous Thromboembolism , Adverse Reactions , Anemia Due , Chronic Kidney Disease , Full Prescribing Information , Anaemia Management , Partial Update , States Renal Data , Data Report , National Institutes , National Institute , Kidney Diseases ,